Liraglutide Reduces Both Atherosclerosis and Kidney Inflammation in Moderately Uremic LDLr-/- Mice.

Liraglutide Reduces Both Atherosclerosis and Kidney Inflammation in Moderately Uremic LDLr-/- Mice.

Chronic kidney disease (CKD) leads to uremia. CKD is characterized by a gradual increase in kidney fibrosis and loss of kidney function, which is associated with a progressive increase in risk of atherosclerosis and cardiovascular death. To prevent progression of both kidney fibrosis and atheroscler...

Full description

Bibliographic Details
Main Authors: Line S Bisgaard, Markus H Bosteen, Lisbeth N Fink, Charlotte M Sørensen, Alexander Rosendahl, Christina K Mogensen, Salka E Rasmussen, Bidda Rolin, Lars B Nielsen, Tanja X Pedersen
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5161477?pdf=render

Internet

http://europepmc.org/articles/PMC5161477?pdf=render

Similar Items